NCT04873596View on ClinicalTrials.gov

Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia

PHASE2RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

June 1, 2024

Study Completion Date

August 1, 2024

Conditions
Procedural Sedation
Interventions
DRUG

Nebulized dexmedetomidine

parturient will receive nebulized 3ug/kg dexmedetomidine.

DRUG

Nebulized midazolam

parturient will receive nebulized 0.2 mg/kg midazolam.

Trial Locations (1)

Unknown

RECRUITING

Zagazig University, Faculty of medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV